Global Oral Thin Films Market Comprehensive Study: Forecasted Market Size And Growth Rate | ZIM Laboratories Limited, NAL Pharma, Cure Pharmaceutical Holding Corp., IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., Sunovion Pharmaceuticals Inc., Seoul Pha

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2595

The Business Research Company offers in-depth market insights through Oral Thin Films Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The oral thin films market size has grown rapidly in recent years. It will grow from $4.07 billion in 2023 to $4.6 billion in 2024 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to patient compliance, pediatric and geriatric patients, rapid drug delivery, chronic diseases, over-the-counter (otc) medications.

The oral thin films market size is expected to see rapid growth in the next few years. It will grow to $7.65 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to specialty pharmaceuticals, precision medicine, mental health medications, oral vaccines, telemedicine services. Major trends in the forecast period include drug delivery technologies, remote care, bioavailability enhancement, travel and on-the-go usage, allergen-free formulations.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=6067&type=smp

Market Segmentation:
The main types of oral thin films include sublingual film and fast dissolving dental/buccal film. The sublingual film refers to oral thin films that rapidly dissolve under the tongue and are quickly absorbed by blood with the help of tissue. It is used to treat patients who are recovering from opioid misuse disorder. These oral thin films are used in the treatment of schizophrenia, migraine, opioid dependence, nausea, and vomiting. They are sold through hospital pharmacies, retail pharmacies, and other distribution channels.

Major Driver - Rising Demand For Thin Film Drug Delivery Systems Fueling Growth In The Oral Thin Film Market
Rising demand for thin film drug delivery systems is propelling the growth of the oral thin film market. Thin films have been identified as a potential alternative to standard dosage forms. It is a convenient, self-administrable, and fast-dissolving dosage form for the delivery of medications, which makes it a versatile drug delivery platform. Thin films are taken orally and do not require water to be swallowed to absorb a drug. OTF is more patient-friendly due to its rapid dissolution rate. Due to these reasons, the demand for thin-film drug delivery systems is increasing, which is bringing more demand for oral thin films as well. For instance, in January 2021, a Turkish Journal of Pharmaceutical Sciences report shows that the global thin-film pharmaceutical products market is expected to increase from $7 billion in 2015 to over $15 billion by the end of 2024. It estimates that there will be an increase of 117% in 10 years. Thus, increasing demand for thin film drug delivery systems is driving the growth of the oral thin film market.

Competitive Landscape:
Major companies operating in the oral thin films market include ZIM Laboratories Limited, NAL Pharma, Cure Pharmaceutical Holding Corp., IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., Sunovion Pharmaceuticals Inc., Seoul Pharma Co. Ltd., Aquestive Therapeutics Inc., Shilpa Therapeutics Pvt. Ltd., Mylan Inc., LIVKON Pharmaceuticals Pvt. Ltd., Panacea Biotec Ltd., Adare Pharmaceuticals Inc., APR Applied Pharma Research SA, BioDelivery Sciences International Inc., Sumitomo Dainippon Pharma Co. Ltd., Indivior PLC, LTS Lohmann Therapie-Systeme AG, Tesa Labtec GmbH, Pfizer Inc., Sanofi S.A., Merck & Co. Inc., Novartis International AG, Roche Holding AG, Johnson & Johnson, GlaxoSmithKline plc, Bayer AG, Eli Lilly and Company, AbbVie Inc., Bristol-Myers Squibb Company, Novo Nordisk A/S, AstraZeneca plc

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report

Top Trend - Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers
Major companies operating in the oral thin films market are focusing on innovative products such as Rizaport to drive revenues in their market. Rizaport is a brand-name oral thin-film formulation that contains rizatriptan benzoate, an agonist of the 5-HT1 receptor and the active ingredient of Merck & Co.'s Maxalt. For instance, in September 2021, IntelGenx Technologies Corp. a Canada-based pharmaceutical company that specializes in the development of oral thin film drug delivery products launched Rizaport. Rizatriptan belongs to the class of chemicals called oral triptans that constrict blood vessels in the brain to treat migraine symptoms, including swelling, and is regarded as one of the most effective triptans. It releases its active ingredient in the tongue and dissolves quickly. Rizaport oral soluble film administration method, which does not require the patient to swallow a pill or drink water, in addition to its neutral flavor, offers a therapeutic alternative for migraine patients. This is particularly beneficial for patients with dysphagia (difficulty swallowing) and migraine-related nausea, which is thought to affect about 80% of migraine patients .

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Oral Thin Films Market Characteristics
3. Oral Thin Films Market Trends And Strategies
4. Oral Thin Films Market - Macro Economic Scenario
5. Oral Thin Films Market Size And Growth
…..
27. Oral Thin Films Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.